tiprankstipranks
Swedish Orphan Biovitrum Ab (MX:SOBIN)
LSE:SOBIN
Mexico Market
SOBIN
Swedish Orphan Biovitrum AB
RESEARCH TOOLSreports

Swedish Orphan Biovitrum AB (SOBIN) Stock News & Sentiment

0 Followers
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
Premium
Company Announcements
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
6d ago
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
Premium
Ratings
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
13d ago
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
27d ago
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
Premium
Company Announcements
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
27d ago
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
Premium
Ratings
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
1M ago
Mitchell Kapoor Reiterates Buy on Swedish Orphan Biovitrum, Maintains SEK575 12-Month Price Target Amid Solid Late-Stage Pipeline and CEO Transition
Premium
Ratings
Mitchell Kapoor Reiterates Buy on Swedish Orphan Biovitrum, Maintains SEK575 12-Month Price Target Amid Solid Late-Stage Pipeline and CEO Transition
1M ago
Sobi CEO Guido Oelkers to Step Down in Early 2027
Premium
Company Announcements
Sobi CEO Guido Oelkers to Step Down in Early 2027
1M ago
More MX:SOBIN News >

SOBIN News on the Web

Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
TipRanks News
Bullish
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
TipRanks News
Bullish
Sobi CEO Guido Oelkers to Step Down in Early 2027
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
MX:SOBIN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is MX:SOBIN’s Media Buzz Sentiment?
1 articles about MX:SOBIN were published this week. In an average week, 1.5 articles are published.
    What is MX:SOBIN’s weekly average amount of articles?
    In an average week, 1.5 articles about MX:SOBIN are published.
      What is MX:SOBIN’s News Sentiment?
      100% of articles about MX:SOBIN were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week